The Leaf THE LEAF July-August 2017 | Page 7

While Jenny Hallam was raided by South Australian police on January 4 this year. Ms Hallam was supplying around 100 patients throughout the country. She’s now facing up to 10 years imprisonment for providing cannabis oil to patients for free. Even though, it’s a similar product to what the government is importing from overseas. An Australian medicinal cannabis pioneer Dr Andrew Katelaris is a medicinal cannabis producer. He began experimenting with the medical uses of the plant in the early 1990s, and he currently acts as a consultant at the Ubuntu Wellness Clinic. In 1997, Katelaris was granted the state’s first industrial hemp licence and he was also granted a licence to grow medicinal plants in 2001. However, both licences were revoked after the NSW health minister was replaced. Over recent years, the doctor has been working with over 50 children with serious seizure disorders, including intractable epilepsy, and providing them with medicine. He believes it’s “obscene” that the government is importing medicine from overseas, when it can be and is being produced in Australia. “We can support the average small child for about $150 a month,” Dr Katelaris told Sydney Criminal Lawyers. “The equivalent pharmaceutical cannabis from GW Pharmaceuticals is $1,500 a month.” The problem is the TGA Australian Greens leader Richard Di Natale introduced the Regulator of Medicinal Cannabis Bill into federal parliament in November 2014. It sought to establish an independent regulator to oversee the establishment of a system of legalised medical marijuana. But the Health Department had concerns, as the new regulatory system might conflict with the Therapeutic Goods Act. Senator Di Natale stressed the independence of the new system, as the TGA markets pharmaceuticals and doesn’t issue approval for herbal medicines. The Greens bill was ideal as it sidestepped the TGA, Dr Katelaris explained. However, “Turnbull wouldn’t support that and instead he put up his own bill, which put it under complete TGA control.” This was the Narcotic Drugs Amendment Bill 2016 that was passed in February last year. According to Katelaris, “the big issue” is that the TGA are trying to turn medical marijuana into a pharmaceutical-only product. While producers like himself don’t have a problem with pharmaceutical cannabis products, they want “unregulated home growing” established as well. The three-tiered system Medical marijuana producers in Australia are calling for a moratorium on arrests and an end to prohibition. And as Dr Katelaris outlines they want a three-tiered system to be established, which would comprise of “home growing, proxy growing and pharmaceutical production.” Home growing would allow people to produce their own medicine cheaply. Proxy growing groups would be set up to cultivate small plantations, providing for people who couldn’t grow their own. And then, pharmaceutical companies registered with the TGA could produce medicine that is only available by prescription. However, the current system only allows for the third tier: patented medical preparations, which will be produced by big pharmaceutical companies. And as medicinal cannabis advocates will tell you, these products are vastly inferior to the herbal preparations. “We see it as a food supplement, rather than a drug. They’re trying to make a full pharmaceutical drug out of it, which it’s not,” Dr Katelaris concluded. “The TGA is the price maintenance unit for big pharmaceutical corporations.”